Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
2
RXST Quote, Financials, Valuation and Earnings
Last price:
$7.37
Seasonality move
:
-12.36%
Day range:
$7.21 - $7.60
52-week range:
$6.32 - $58.23
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.95x
P/B ratio:
1.06x
Volume:
1.2M
Avg. volume:
1.5M
1-year change:
-85.27%
Market cap:
$295.8M
Revenue:
$139.9M
EPS (TTM):
-$0.67
Earnings Data
Next earnings date for RXST
Aug 05
2025
Most recent earnings per share
-$0.20
Missed by $0.12
(May 7/2025)
Consensus Estimate
-$0.08
(May 7/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RXST Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $26M | -- | -- | -$0.17 | -- |
| 08/05/2025 | Q2 | $33.6M | -- | -- | -$0.11 | -- |
| 05/07/2025 | Q1 | $37.9M | $37.9M | -$0.20 | -$0.08 | -$0.12 |
| 02/25/2025 | Q4 | $40.2M | $40.2M | -$0.15 | -$0.01 | -$0.14 |
| 11/07/2024 | Q3 | $35.1M | $35.3M | -$0.16 | -$0.07 | -$0.09 |
| 08/05/2024 | Q2 | $32.1M | $34.9M | -$0.16 | -$0.11 | -$0.05 |
| 05/06/2024 | Q1 | $27.6M | $29.5M | -$0.25 | -$0.19 | -$0.06 |
| 02/28/2024 | Q4 | $27.9M | $28.6M | -$0.25 | -$0.27 | $0.02 |
| 11/09/2023 | Q3 | -- | -- | -$0.35 | -$0.35 | $0.00 |
| 08/07/2023 | Q2 | -- | -- | -$0.40 | -$0.39 | -$0.01 |
| 05/09/2023 | Q1 | -- | -- | -$0.42 | -$0.45 | $0.03 |
| 03/06/2023 | Q4 | -- | -- | -$0.56 | -$0.74 | $0.18 |
| 11/07/2022 | Q3 | -- | -- | -$0.61 | -$0.68 | $0.07 |
| 08/08/2022 | Q2 | -- | -- | -$0.61 | -$0.65 | $0.04 |
| 05/05/2022 | Q1 | -- | -- | -$0.64 | -- | -- |
| 03/08/2022 | Q4 | -- | -- | -$0.58 | -- | -- |
| 11/10/2021 | Q3 | -- | -- | -$0.68 | -- | -- |
| 09/07/2021 | Q2 | -- | -- | -$0.51 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.36 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | $0.96 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | $0.31 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.89 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$1.09 | -- | -- |
RxSight Earnings Questions
-
How Much did RxSight Generate in Revenue Last Quarter?
RxSight reported $37.9M worth of top line sales in its most recent quarter.
-
Did RxSight Beat Earnings Last Quarter?
RxSight announced earnings per share of -$0.20 which represents a miss of analyst forecast a -$0.08 per share.
-
Is RxSight Profitable?
RxSight reported $28.3M that represents $0.70 per share over the last quarter.
-
What is the Analyst Consensus for RxSight EPS Next Year?
RxSight's earnings are forecast to decrease from -$0.71 per share to -$0.11 per share next year representing a decrease of -82.8%.
-
When is RxSight's Earnings Date?
RxSight's next earnings date is August 5, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
